Literature DB >> 3561407

Cotransfection with adenovirus DNA enhances transcription from linear DNA containing eucaryotic promoters.

M B Vasudevachari, V Natarajan, N P Salzman.   

Abstract

Linear DNAs, containing a copy of the adenovirus serotype 2 (Ad2) inverted terminal repeat sequence at each end, replicate in 293 cells when cotransfected with Ad2 DNA (Hay et al., J. Mol. Biol. 175:493-510, 1984). We have linked either the Ad2 IVa2 promoter (IVa2) or major late promoter (MLP) to the chloramphenicol acetyltransferase gene and inserted this DNA into such a plasmid (pARKR) between its two inverted terminal repeats. These recombinant plasmids were linearized and then used to transfect 293 cells in the presence or absence of Ad2 helper DNA. Synthesis of IVa2 and MLP RNAs, and production of chloramphenicol acetyltransferase was increased dramatically when the Ad2 DNA was included. However, unlike the patterns of temporal regulation which are seen during a cycle of virus replication when these genes are contained within the virion, there was no obvious difference in the timing of RNA synthesis from plasmid IVa2 or MLP after cotransfection. When linearized plasmids containing IVa2 and MLP sequences but lacking inverted terminal repeats at their ends (replication deficient plasmids) were used for transfection, an increase in RNA synthesis from IVa2 or MLP was also observed and similarly required cotransfection with Ad2 DNA. When HeLa cells, which do not constitutively express the adenovirus E1a gene, were cotransfected with linearized plasmids and adenovirus DNA that lacks the E1a region (H5dl312), a stimulation of transcription was also observed, although it was less than the level observed with wild-type DNA. The results of the present study demonstrate that an early gene product(s) besides E1a functions in trans to regulate transcription.

Mesh:

Substances:

Year:  1987        PMID: 3561407      PMCID: PMC365177          DOI: 10.1128/mcb.7.3.1063-1069.1987

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  39 in total

1.  Characteristics of a human cell line transformed by DNA from human adenovirus type 5.

Authors:  F L Graham; J Smiley; W C Russell; R Nairn
Journal:  J Gen Virol       Date:  1977-07       Impact factor: 3.891

2.  An adenovirus type 5 early gene function regulates expression of other early viral genes.

Authors:  N Jones; T Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

3.  Template requirements for in vivo replication of adenovirus DNA.

Authors:  J A Bernstein; J M Porter; M D Challberg
Journal:  Mol Cell Biol       Date:  1986-06       Impact factor: 4.272

4.  Effect of cycloheximide on RNA metabolism early in productive infection with adenovirus 2.

Authors:  E A Craig; H J Raskas
Journal:  J Virol       Date:  1974-07       Impact factor: 5.103

5.  Biochemical studies on adenovirus multiplication. 18. Resolution of early virus-specific RNA species in Ad 2 infected and transformed cells.

Authors:  J T Parsons; M Green
Journal:  Virology       Date:  1971-07       Impact factor: 3.616

6.  Definition and mapping of adenovirus 2 nuclear transcription.

Authors:  J R Nevins
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

7.  Organization and expression of the left third of the genome of adenovirus.

Authors:  J B Lewis; H Esche; J E Smart; B W Stillman; M L Harter; M B Mathews
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1980

8.  Human adenoviruses: growth, purification, and transfection assay.

Authors:  M Green; W S Wold
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

9.  Regulation of the appearance of cytoplasmic RNAs from region 1 of the adenovirus 2 genome.

Authors:  D J Spector; M McGrogan; H J Raskas
Journal:  J Mol Biol       Date:  1978-12-15       Impact factor: 5.469

10.  Pre-early adenovirus 5 gene product regulates synthesis of early viral messenger RNAs.

Authors:  A J Berk; F Lee; T Harrison; J Williams; P A Sharp
Journal:  Cell       Date:  1979-08       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.